26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
Dr Keir Shiels at a district general hospital describes a measure to tackle delays in discharging patients: a satellite dispensary in a paediatric discharge lounge.
13 August 2019
Last week, NICE published draft recommendations on the use of cannabis-based medicinal products (CBMPs) following evaluation of their clinical and cost-effectiveness, and NHS England published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products where it is safe ...
The use of unlicensed medicines or licensed medicines for unlicensed applications in paediatric practice
This statement, originally produced in 2000, was updated in 2013 by the Joint Standing Committee on Medicines, a committee of the Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group. The update reflects changes in European (including UK) law that aim to fa...
The RCPCH quality improvement sharing hub where you can find resources and examples of interventions in a number of clinical practice areas. Launched in March 2019 and refreshed in October 2020.
The aim of this evidence-based statement is to summarise the current knowledge about delayed prescriptions (also called backup prescriptions) for antibiotics and to highlight the special issues that must be taken into account when considering the need for a delayed prescription in infants and childr...
NPDA Results Online was developed in response to consultations with the paediatric diabetes community who told us they wanted to view and compare the results of NPDA unit level summaries in a more accessible way. See below for some tips on how to use it, or download our user guide.
Paediatricians and other clinicians often have to take very difficult decisions while acting in strict accordance with the law and with sensitivity towards the customs and beliefs practiced by their patients and their patients' families. These resources are intended to support the training and crit...